ANALISIS BIAYA TERAPI STROKE HEMORAGI PADA PASIEN RAWAT INAP DI RS PKU MUHAMMADIYAH YOGYAKARTA NOVEMBER 2011-2013

Stroke is the third death factors in the US after heart disease and cancers. It is suggested that the cost for dealing with stroke will be doubled in. This research was conducted in early 2014 coincide with the implementation of JKN (National Health Insurance) where the Indonesian government commenced health insurance for all people regardless of their occupation. In the era of cost concerned social health insurance, the research on economic pharmacology is an important aspect. The research was aimed at the following objectives: 1) to calculate the cost components and the average cost of patients for full hemorrhagic stroke therapy, 2) to know which cost component(s) that contribute to the highest proportion of the therapeutic cost, 3) to know the average cost of hospitalized patients for full hemorrhagic stroke therapy based on the payer and the class of hospital service, 4) to know whether there are effects of patient�s factor, payment types, and hospital service class on the total therapeutic cost, and 5) to know whether the real cost of hemorrhagic stroke therapy of hospitalized patients is matched with the cost reimbursed by health insurance company based on INA-CBGs 2014. The study was a type of non-experimental research using cross sectional analytical design according to the hospital�s perspective. Sampling method was done retrospectively from the available medical records data of hemorrhagic stroke patients along with their medical cost. The research subjects were all patients that diagnosed with hemorrhagic stroke and hospitalized in the RS PKU Muhammadiyah Yogyakarta from the period of November 2011-2013, and all data must fulfill with the inclusive criteria. Research variables were demographic characteristics including age and gender, comorbid factor of hemorrhagic stroke, payer, class of hospital service, total cost during therapy (direct medical cost and direct non medical cost). Data were analyzed with Pearson correlation, ANOVA, and Mann-Whitney. Results showed that there was no effect of patients� characteristics, number of comorbid factors, and payer on the total cost of therapeutic patients. The total cost was affected by the hospital class service. Otherwise, for comparison with medication cost, only gender and payer which has significant influence.The real average cost of hemorrhagic stroke therapy at RS PKU Muhammadiyah Yogyakarta was significantly higher than the cost issued by INACBGs era JKN 2014. Key words: hemorrhagic stroke, cost analyses, INA-CBGs, patients� characteristics, comorbid factor, payer, class of hospital servic